未用药首发精神病患者TSPO胶质细胞标志物PET降低
该研究用PET和TSPO放射性配体[11C]PBR28检查16例未用药首发精神病患者与16名健康对照,发现患者灰质分布容积VT显著降低,提示早期精神分裂症脑内免疫细胞数量减少或功能改变。
要点
- 未用药首发精神病患者灰质[11C]PBR28 VT较健康对照显著降低。
- 分析控制TSPO基因型与性别后,患者多个感兴趣区VT降低仍显著。
- 灰质VT与临床或认知指标在多重比较校正后无相关。
核心结论
- 观察到的TSPO结合降低提示早期精神分裂症脑内免疫细胞数量减少或功能改变。
研究设计与样本
- 研究纳入16例未用药首发精神病患者和16名健康对照,采用PET与TSPO放射性配体[11C]PBR28。
- 主要结局为基于两组织室模型和动脉输入函数计算的灰质分布容积VT。
- 统计分析控制已知影响[11C]PBR28结合的TSPO基因型及性别。
主要发现
- 患者灰质[11C]PBR28 VT较健康对照显著降低。
- 患者次要感兴趣区的[11C]PBR28 VT也较健康对照显著降低。
- 多重比较校正后,灰质VT与临床或认知指标无相关。
临床怎么用
- 该研究提示未用药首发精神病患者脑内TSPO结合降低,与既往用药患者研究结果不同,解读TSPO PET结果时需考虑抗精神病药物暴露。
局限性
- 样本量较小,仅16例患者和16名对照。
- 既往研究多涉及抗精神病药物暴露,可能影响免疫细胞活性并限制结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Several lines of evidence are indicative of a role for immune activation in the pathophysiology of schizophrenia. Nevertheless, studies using positron emission tomography (PET) and radioligands for the translocator protein (TSPO), a marker for glial activation, have yielded inconsistent results. Whereas early studies using a radioligand with low signal-to-noise in small samples showed increases in patients, more recent studies with improved methodology have shown no differences or trend-level decreases. Importantly, all patients investigated thus far have been on antipsychotic medication, and as these compounds may dampen immune cell activity, this factor limits the conclusions that can be drawn. Here, we examined 16 drug-naive, first-episode psychosis patients and 16 healthy controls using PET and the TSPO radioligand [11C]PBR28. Gray matter (GM) volume of distribution (VT) derived from a two-tissue compartmental analysis with arterial input function was the main outcome measure. Statistical analyses were performed controlling for both TSPO genotype, which is known to affect [11C]PBR28 binding, and gender. There was a significant reduction of [11C]PBR28 VT in patients compared with healthy controls in GM as well as in secondary regions of interest. No correlation was observed between GM VT and clinical or cognitive measures after correction for multiple comparisons. The observed decrease in TSPO binding suggests reduced numbers or altered function of immune cells in brain in early-stage schizophrenia.
引用
- Collste K, Plavén-Sigray P, Fatouros-Bergman H, et al. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28. Mol Psychiatry. 2017. PMID: 28194003. doi:10.1038/mp.2016.247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。